MedTrace Logo

Skeletal Events of Hormonal Treatment and Radiotherapy in Patient With Breast Cacer

NCT04792840 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-03-11

No results posted yet for this study

Summary

study of lymphedema and skeletal events in breast cacer patient receiving adjuvant hormonal therapy and radiothearpy

Conditions

Interventions

DRUG

Femara Pill

study effect on bone

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • hanan g. mostafa, prof dr · Assiut University

  • mohammed a. mohmmed, dr · Assiut University

  • maha s. el naggar, dr · Assiut University

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792840 on ClinicalTrials.gov